Mutoh T, Shirai T, Ishii T, Shirota Y, Fujishima F, Takahashi F, Kakuta Y, Kanazawa Y, Masamune A, Saiki Y, Harigae H, Fujii H. Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis. Nat Commun. 2020 Mar 9;11(1):1253. doi: 10.1038/s41467-020-15088-0. PMID: 32152303; PMCID: PMC7062749.
Ichikawa S, Furukawa E, Saito K, Fukuhara N, Onodera K, Onishi Y, Yokoyama H, Ichinohasama R, Harigae H. Sustained remission of giant pancreatic plasmacytoma with daratumumab. Ann Hematol. 2020 Jun 18. doi: 10.1007/s00277-020-04145-9. Epub ahead of print. PMID: 32556544.
Ichikawa S, Fukuhara N, Shirai T, Ishii T, Ichinohasama R, Harigae H. Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus. Int J Hematol. 2020 Jun 8. doi: 10.1007/s12185-020-02914-w. Epub ahead of print. PMID: 32514927.
Ichikawa S, Saito K, Fukuhara N, Tanaka Y, Lee Y, Onodera K, Onishi Y, Yokoyama H, Fujiwara M, Harigae H. Successful Treatment of Life-threatening Bleeding Caused by Acquired Factor X Deficiency Associated with Respiratory Infection. Intern Med. 2020 May 15;59(10):1303-1308. doi: 10.2169/internalmedicine.4142-19. Epub 2020 Feb 5. PMID: 32023586; PMCID: PMC7303456.
Ichikawa S, Fukuhara N, Saito K, Yokoyama H, Onodera K, Onishi Y, Ichinohasama R, Harigae H. Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab. Leuk Lymphoma. 2020 Jun;61(6):1504-1507. doi: 10.1080/10428194.2020.1713322. Epub 2020 Jan 21. PMID: 31960738.
Ichikawa S, Fukuhara N, Saito K, Onodera K, Shirai T, Onishi Y, Yokoyama H, Fujii H, Ichinohasama R, Harigae H. Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series. Int J Hematol. 2020 May;111(5):667-672. doi: 10.1007/s12185-020-02822-z. Epub 2020 Jan 18. PMID: 31955346.
Ichikawa S, Fukuhara N, Watanabe S, Okitsu Y, Onodera K, Onishi Y, Harigae H. Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis. J Infect Chemother. 2020 Feb;26(2):292-295. doi: 10.1016/j.jiac.2019.08.022. Epub 2019 Sep 28. PMID: 31570321.
Ichikawa S, Sasaoka A, Fukuhara N, Okitsu Y, Onishi Y, Ichihohasama R, Harigae H. Primary ovarian diffuse large B-cell lymphoma preceded by autoimmune hemolytic anemia. J Hematopathol. 2020;13(1):63-67. doi: 10.1007/s12308-019-00377-5.
Shirai T, Mori Y, Izumiyama T, Fujii H, Ishii T, Harigae H. Rheumatoid Arthritis After Cord Blood Cell Transplantation. J Clin Rheumatol. 2020 Jun 12. doi: 10.1097/RHU.0000000000001430. Epub ahead of print. PMID: 32541615.
Shirai T, Komatsu H, Sato H, Fujii H, Ishii T, Harigae H. Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor. Intern Med. 2020 Jun 15;59(12):1559-1563. doi: 10.2169/internalmedicine.4331-19. Epub 2020 Mar 19. PMID: 32188815.
Shirai T, Murakami K, Fujii H, Ishii T, Harigae H. Comment on: Aortarctia: a rare manifestation of relapsing polychondrits. Rheumatology (Oxford). 2020 Jul 1;59(7):1784-1785. doi: 10.1093/rheumatology/keaa019. PMID: 32025723.
Yokoyama H, Takenaka K, Nishida T, Seo S, Shinohara A, Uchida N, Tanaka M, Takahashi S, Onizuka M, Kozai Y, Yasuhiro S, Ozawa Y, Katsuoka Y, Doki N, Sawa M, Kimura T, Kanda J, Fukuda T, Atsuta Y, Nakasone H; Japan Society for Hematopoietic Cell Transplantation Transplantation-Related Complication Working Group. Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or Type. Biol Blood Marrow Transplant. 2020 Jul;26(7):1363-1370. doi: 10.1016/j.bbmt.2020.04.002. Epub 2020 Apr 18. PMID: 32311477.
Yokoyama H, Morishima Y, Fuji S, Uchida N, Takahashi S, Onizuka M, Tanaka M, Yuju O, Eto T, Ozawa Y, Takada S, Takanashi M, Kato K, Kanda Y, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation. Biol Blood Marrow Transplant. 2020 Mar;26(3):519-528. doi: 10.1016/j.bbmt.2019.11.001. Epub 2019 Nov 9. PMID:31715305.
Ishii Y, Fujii H, Sugimura K, Shirai T, Hoshi Y, Fujita Y, Shirota Y, Ishii T, Shimokawa H, Harigae H. Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody. Case Rep Rheumatol. 2020 Feb 25;2020:1926908. doi: 10.1155/2020/1926908. PMID: 32158583; PMCID: PMC7061130.
Okazaki S, Watanabe R, Kondo H, Kudo M, Harigae H, Fujii H. High Relapse Rate in Patients with Polymyalgia Rheumatica despite the Combination of Immunosuppressants and Prednisolone: A Single Center Experience of 89 patients. Tohoku J Exp Med. 2020 Jun;251(2):125-133. doi: 10.1620/tjem.251.125. PMID: 32581186.
Okazaki S, Watanabe R, Harigae H, Fujii H. Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis. Tohoku J Exp Med. 2020 Mar;250(3):153-159. doi: 10.1620/tjem.250.153. PMID: 32132324.
Takahashi T, Ichikawa S, Ichinohasama R, Harigae H. BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1? Leuk Lymphoma. 2020 May;61(5):1265-1267. doi: 10.1080/10428194.2019.1706736. Epub 2019 Dec 26. PMID: 31876209.
Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K. A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemia. Cancer Sci. 2020 Jul 8. doi: 10.1111/cas.14561. Epub ahead of print. PMID: 32639651.
Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, Ito Y, Fukuhara N, Hirose A, Takeda Y, Makita M, Endo T, Kimura SI, Ishimura M, Miura O, Ohga S, Kimura H, Fujiwara S, Arai A. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020 Jul 14;4(13):2918-2926. doi: 10.1182/bloodadvances.2020001451. PMID: 32598475; PMCID: PMC7362364.
Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y, Yonezawa H, Asai K, Fukuhara N, Sugiyama K, Shinojima N, Kitagawa J, Aoi A, Nishikawa R. Phase 1/2 Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Relapsed/Refractory Primary Central Nervous System Lymphoma. Neuro Oncol. 2020 Jun 25:noaa145. doi: 10.1093/neuonc/noaa145. Epub ahead of print. PMID: 32583848.
Maruyama D, Iida S, Ogawa G, Fukuhara N, Seo S, Miyazaki K, Yoshimitsu M, Kuroda J, Tsukamoto N, Tsujimura H, Hangaishi A, Yamauchi T, Utsumi T, Mizuno I, Takamatsu Y, Nagata Y, Minauchi K, Ohtsuka E, Hanamura I, Yoshida S, Yamasaki S, Suehiro Y, Kamiyama Y, Tsukasaki K, Nagai H. Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105). Br J Haematol. 2020 Jun 24. doi: 10.1111/bjh.16878. Epub ahead of print. PMID: 32583431.
Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Goto T, Kohno A, Ozeki K, Onishi Y, Fukuhara N, Fujii N, Yokoyama H, Kasai M, Iida H, Kanemura N, Endo T, Ago H, Onizuka M, Iyama S, Nawa Y, Nakamae M, Nagata Y, Kurahashi S, Tomiya Y, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2020 Jul;55(7):1399-1409. doi: 10.1038/s41409-020-0859-8. Epub 2020 Mar 16. PMID: 32203259.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. PMID: 32171071.
Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Sakai R, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, Yoshida S, Kojima M, Takahashi H, Tomita A, Atsuta Y, Maruyama D, Tanaka E, Suzuki T, Kinoshita T, Ogura M, Ueda R, Mizokami M. Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma. J Hepatol. 2020 Mar 17:S0168-8278(20)30167-7. doi: 10.1016/j.jhep.2020.03.009. Epub ahead of print. PMID: 32194183.
Yabe H, Tabuchi K, Uchida N, Takahashi S, Onishi Y, Aotsuka N, Sugio Y, Ikegame K, Ichinohe T, Takahashi M, Kato K, Atsuta Y, Kanda Y. Could the minimum number of haematopoietic stem cells to obtain engraftment exist in unrelated, single cord blood transplantation? Br J Haematol. 2020 Apr;189(2):e56-e60. doi: 10.1111/bjh.16465. Epub 2020 Feb 28. PMID: 32108331.
Nishikawa K, Kimura K, Kanda Y, Sugiyama M, Kakihana K, Doki N, Ohashi K, Bae SK, Takahashi K, Ishihara Y, Mizuno I, Onishi Y, Onozawa M, Onizuka M, Yamamoto M, Ishikawa T, Inoue K, Kusumoto S, Hashino S, Saito H, Kanto T, Sakamaki H, Mizokami M. A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 Jul;55(7):1388-1398. doi: 10.1038/s41409-020-0833-5. Epub 2020Feb 18. PMID: 32071416; PMCID: PMC7329632.
Harada K, Fuji S, Seo S, Kanda J, Ueki T, Kimura F, Kato K, Uchida N, Ikegame K, Onizuka M, Matsuoka KI, Doki N, Kawakita T, Onishi Y, Yano S, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Ogata M; transplant complications working group of the Japan Society for Hematopoietic Cell Transplantation. Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 Feb 12. doi: 10.1038/s41409-020-0821-9. Epub ahead of print. PMID: 32051535.
Ichikawa S, Saito K, Fukuhara N, Yokoyama H, Onodera K,Onishi Y, Ichinohasama R, Harigae H. Primary adrenal extranodal NK/T-cell lymphoma: A case report and literature review. Leuk Res Rep. 2020 Sep 28;14:100223. doi: 10.1016/j.lrr.2020.100223. eCollection 2020. https://pubmed.ncbi.nlm.nih.gov/33024692/
Ichikawa S, Fukuhara N, Shirai T, Ishii T, Ichinohasama R , Harigae H. Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus. Case Reports Int J Hematol. 2020 Oct;112(4):592-596. doi: 10.1007/s12185-020-02914-w. Epub 2020 Jun 8. https://pubmed.ncbi.nlm.nih.gov/32514927/
Yasushi Onishi , Hisayuki Yokoyama , Yuna Katsuoka , Toshihiro Ito , Tomohumi Kimura , Joji Yamamoto , Shinji Nakajima , Osamu Sasaki , Takahide Ara , Koichiro Minauchi , Osamu Fukuhara , Naoki Kobayashi , Hideyoshi Noji , Shuichi Ota , Hideo Harigae. Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma. Ann Hematol. 2020 Oct;99(10):2351-2356. doi: 10.1007/s00277-020-04240-x. Epub 2020 Aug 31. https://pubmed.ncbi.nlm.nih.gov/32865607/
Ichikawa S , Fukuhara N, Saito K , Furukawa E, Onodera K , Onishi Y, Yokoyama H, Ichinohasama R, Harigae H. Successful Treatment of Primary Refractory Angioimmunoblastic T-cell Lymphoma With Cord Blood Transplantation. Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):e926-e929. doi: 10.1016/j.clml.2020.07.009. Epub 2020 Jul 22. https://pubmed.ncbi.nlm.nih.gov/32792303/
Fukuhara N, Kinoshita T, Yamamoto K, Nagai H , Izutsu K, Yamamoto G, Bhargava P, Rajakumaraswamy N, Humeniuk R, Mathias A, Xing G, Fukui M, Tobinai K. Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia. Jpn J Clin Oncol. 2020 Dec 16;50(12):1395-1402. doi: 10.1093/jjco/hyaa153. https://pubmed.ncbi.nlm.nih.gov/32856068/